Tarsus Pharmaceuticals, Inc.
SEC Filing List
TARS CIK: 0001819790
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | ADVISER COMPLIANCE ASSOCIATES LLC /fa | 05/15/2026 | |||
| SCHEDULE 13G | 05/15/2026 | ||||
| SCHEDULE 13G/A | 05/08/2026 | ||||
| 8-K | Current report filing | Tarsus Pharmaceuticals, Inc. | 05/06/2026 | ||
| SCHEDULE 13G/A | 05/06/2026 | ||||
| 10-Q | Quarterly report pursuant to Section 13 ... | Tarsus Pharmaceuticals, Inc. | 05/06/2026 | ||
| ARS | Annual report to security holders | Tarsus Pharmaceuticals, Inc. | 04/28/2026 | ||
| 4 | Statement of changes in beneficial owner... | Pyott David E I | Tarsus Pharmaceuticals, Inc. | 04/28/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Tarsus Pharmaceuticals, Inc. | 04/28/2026 | ||
| DEF 14A | Definitive proxy statements | Tarsus Pharmaceuticals, Inc. | 04/28/2026 | ||
| No record found. | |||||
| Load More | |||||
